Skip to main content

Security report for sp-institute.com

Johnson & Johnson MedTech · Healthcare · N/a

Low risk. 3 critical or high findings in GDPR outside view, Email security and 1 other check.

Security score

78/100

Risk levelLow

0–100, higher is better. How it is calculated

Johnson & Johnson MedTech operates a professional website targeting healthcare professionals in the Europe, Middle East, and Africa (EMEA) region. The site provides a secure opt-in form for marketing communications and product information, supported by strong branding and compliance with privacy regulations. The technical infrastructure leverages modern web technologies including Bootstrap, jQuery, Google Tag Manager, and OneTrust for cookie consent, ensuring a responsive and user-friendly experience. Security measures such as HTTPS and Google reCAPTCHA are implemented, although explicit security headers are not visible in the HTML content. The absence of WHOIS data for the subdomain is consistent with internal corporate domain usage, and the overall site legitimacy is high based on content and branding.

Scanned

This is an earlier scan of sp-institute.com. View the latest report

NIS2 and GDPR posture

GDPR outside view
68/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • High

      No SPF record found

      SPF helps prevent email spoofing

      What to do: Add SPF record: "v=spf1 include:_spf.yourmailprovider.com ~all"

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching sp-institute.com

This scan found 17 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
77
Security headers
85
Email security
50
DNS health
85
Network security
100
GDPR outside view
68
Average
78

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The website serves as a digital touchpoint for Johnson & Johnson MedTech's marketing and customer engagement in the EMEA region. It supports a B2B business model focused on healthcare professionals, offering product information and customer service. The company is a subsidiary of Johnson & Johnson, a global healthcare leader. The site’s integration with marketing tools and compliance frameworks indicates a mature digital marketing strategy. The lack of direct phone contact suggests reliance on email and web forms for communication. The site’s external links and policies reflect a strong commitment to privacy and regulatory compliance, important in the healthcare sector.

Security posture

The website demonstrates a solid security posture with enforced HTTPS, use of Google reCAPTCHA to prevent automated abuse, and OneTrust cookie consent for GDPR compliance. However, the absence of visible security headers such as Content Security Policy (CSP), HSTS, and X-Frame-Options suggests room for improvement. No vulnerabilities or exposed sensitive data were detected in the HTML content. Incident response and security policy information are not publicly available on the site, which could be enhanced to improve transparency and readiness. Overall, the site aligns well with industry best practices for healthcare digital properties.

Recommendations

  1. Implement and verify HTTP security headers including CSP, HSTS, X-Frame-Options, and X-XSS-Protection to enhance browser security.
  2. Publish clear security and incident response policies accessible to users and partners to improve transparency.
  3. Regularly audit and update third-party libraries to mitigate potential vulnerabilities.
  4. Consider adding explicit contact phone numbers for customer support to improve accessibility.
  5. Enhance accessibility features to meet higher standards and improve user experience for all users.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Johnson & Johnson MedTech
Description
Johnson & Johnson MedTech provides medical technologies and solutions targeting healthcare professionals in Europe, Middle East, and Africa. The site offers product information, customer service, and marketing opt-in forms.
Key services
Medical product information, Customer service, Marketing communications opt-in
Content quality
good
Branding
consistent

Technology

Stack
Bootstrap 4.5.3, jQuery 3.6.0, Font Awesome 5.15.4, Google Fonts (Open Sans), Google Tag Manager, Google reCAPTCHA v3, OneTrust Cookie Consent
Frameworks
Bootstrap
Platforms
Web
Performance
moderate
Mobile
good
Accessibility
basic
SEO
basic

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Google reCAPTCHA integration
  • OneTrust cookie consent banner
  • Form input validation and required fields

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
OneTrust Cookie Consent, Google reCAPTCHA
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is a professional opt-in form for Johnson & Johnson MedTech EMEA region.
  2. No WHOIS data for subdomain, expected for internal corporate subdomains.
  3. Strong privacy and cookie compliance with OneTrust and clear privacy policy links.
  4. Use of Google Tag Manager and reCAPTCHA indicates good security and analytics practices.
  5. No contact phone numbers explicitly listed; contact via email and form only.
  6. No visible security headers in HTML but HTTPS is enforced.
  7. No evidence of malware, phishing, or suspicious content.
  8. Content is healthcare focused and safe for general audiences.
Technical notes

Notes

The website uses a modern and stable technology stack including Bootstrap 4.5.3 for responsive design, jQuery 3.6.0 for DOM manipulation, and Font Awesome for icons. Google Fonts are used for typography, and Google Tag Manager facilitates analytics and marketing tags. The site is hosted on a subdomain of jnjmedtech.com, likely managed internally by Johnson & Johnson. Performance is moderate with asynchronous loading of scripts and optimized assets. Mobile optimization is good, and the site includes cookie consent mechanisms for compliance. No CMS is explicitly detected, suggesting a custom or proprietary platform. The technical implementation is solid but could benefit from enhanced security headers and accessibility improvements.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 81/100Low24 findingsView report
Reviews of this site

Share your experience with sp-institute.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review sp-institute.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.